• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Biotechnology Product Manufacturing in the US Product Image

Biotechnology Product Manufacturing in the US

  • Published: September 2014
  • Region: United States
  • 10 pages
  • First Research

Brief Excerpt from Industry Overview Chapter:

Companies in this industry manufacture drugs, therapies, vaccines, genetically modified food and fuel, and other products based on genetically manipulated compounds. Major companies include US-based Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), and Monsanto, as well as Cangene (Canada), CSL (Australia), Merck KGaA (Germany), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France, owns Genzyme).

The global biotechnology industry includes about 7,000 companies with total revenue of about $120 billion, according to Israeli business magazine Globes. Top regions for biotechnology include the US and Canada, Australia, and Europe, according to Ernst & Young.

The US biotechnology product manufacturing industry includes about 1,800 companies with combined annual revenue of around $90 billion. Because many drugs are now developed using biotechnology, the biotechnology and pharmaceutical industries overlap considerably. Pharmaceutical Manufacturing is covered in a separate industry report.

COMPETITIVE LANDSCAPE

Demand for biotechnology in the fields READ MORE >

Industry Overview
Quarterly Industry Update
Business Challenges
Business Trends
Industry Opportunities
Call Preparation Questions
Financial Information
Industry Forecast
Web Links and Acronyms

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos